We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Allergan, along with Ironwood Pharmaceuticals, has filed a suit against five generics companies, alleging infringement of nine patents covering its irritable bowel syndrome drug, Linzess. Read More